Algorithms and cancer drugs: In silico design of S100B ligands to block p53 binding

被引：0
|
作者：
Whitlow, John L.
Li, Yumin
机构：
[1] NC State Univ, Dept Elect & Comp Engn, Raleigh, NC 27606 USA
[2] E Carolina Univ, Dept Chem, Greenville, NC 27858 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
27-CINF
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Low Energy Conformations for S100 Binding Peptide from the Negative Regulatory Domain of p53
    Carty, Robert P.
    Lin, Bo
    Fridman, Daniel
    Pincus, Matthew R.
    PROTEIN JOURNAL, 2018, 37 (06): : 510 - 517
  • [42] Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53
    Markowitz, J
    Rustandi, RR
    Varney, KM
    Wilder, PT
    Udan, R
    Wu, SL
    Horrocks, WD
    Weber, DJ
    BIOCHEMISTRY, 2005, 44 (19) : 7305 - 7314
  • [43] Structural and thermodynamic characterization of the recognition of the S100-binding peptides TRTK12 and p53 by calmodulin
    Wafer, Lucas N.
    Tzul, Franco O.
    Pandharipande, Pranav P.
    McCallum, Scott A.
    Makhatadze, George I.
    PROTEIN SCIENCE, 2014, 23 (09) : 1247 - 1261
  • [44] The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity
    Mueller, A
    Schäfer, BW
    Ferrari, S
    Weibel, M
    Makek, M
    Höchli, M
    Heizmann, CW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (32) : 29186 - 29193
  • [45] Fragmenting the S100B-p53 Interaction: Combined Virtual/Biophysical Screening Approaches to Identify Ligands
    Agamennone, Mariangela
    Cesari, Lucia
    Lalli, Daniela
    Turlizzi, Elisa
    Del Conte, Rebecca
    Turano, Paola
    Mangani, Stefano
    Padova, Alessandro
    CHEMMEDCHEM, 2010, 5 (03) : 428 - 435
  • [46] Different Oligomeric States of the Tumor Suppressor p53 Show Identical Binding Behavior towards the S100β Homodimer
    Wei, Alan An Jung
    Iacobucci, Claudio
    Schultze, Wiebke
    Ihling, Christian H.
    Arlt, Christian
    Sinz, Andrea
    CHEMBIOCHEM, 2022, 23 (11)
  • [47] CRISPR/dCas9-KRAB-Mediated Suppression of S100b Restores p53-Mediated Apoptosis in Melanoma Cells
    Choudhury, Samrat Roy
    Heflin, Billie
    Taylor, Erin
    Koss, Brian
    Avaritt, Nathan L.
    Tackett, Alan J.
    CELLS, 2023, 12 (05)
  • [48] ASSOCIATION OF p53 EXPRESSION WITH S-100 AND HLA-DR POSITIVE CELLS IN COLORECTAL CANCER PATIENTS
    Gulubova, Maya
    Vasilev, Ivan
    Ivanova, Koni
    Ananiev, Julian
    Ignatova, Maria Magdalena
    Vlaykova, Tatyana
    ANTICANCER RESEARCH, 2014, 34 (10) : 5932 - 5935
  • [49] Structure-based drug design of 3-site binding, high affinity inhibitors of S100B in malignant melanoma
    Cavalier, Michael C.
    Wilder, Paul T.
    Luci, Diane
    Maloney, David J.
    Fang, Lei
    Ansari, Mohd. Innran
    MacKerell, Alexander D.
    Coop, Andrew
    Jadhav, Ajit
    Weber, David J.
    CANCER RESEARCH, 2016, 76
  • [50] Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer
    Kim, Joo Heon
    Kim, Chang Nam
    Kim, Soo Young
    Lee, Jung Sam
    Cho, Daeho
    Kim, Jae Wha
    Yoon, Sun Young
    ONCOLOGY REPORTS, 2009, 22 (01) : 41 - 47
12345